Komori
Toho Acetylene (4093) · InitiativeAdvanced

Research and development of gas production, supply and utilization technologies

First written in FY2016. 24 of 26 entries say "Restated". Latest entry: FY2026.

26entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2026-H12016: 320162017: 420172018: 320182019: 120192020: 120202021: 320212022: 420222023: 320232024: 220242025: 120252026: 12026
Same theme, other companies
Research and development of technologies for the production, supply, and use of industrial gasesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Develops technology to efficiently decompose nitrous oxide, which has a high global warming potential.」

    In addition to conventional cost reduction, safety technology and new application development, specifies R&D into technology for decomposing nitrous oxide with a high global warming potential, as well as equipment and tooling related to espuma. R&D expenses were ¥35 million.
  2. FY2026-H1RestatedAnnual report

    「R&D expenses for the current interim consolidated accounting period totaled ¥18 million. There were no material changes in the status of the Group’s R&D activities during the current interim consolidated accounting period.」

    Reconfirms that there were no material changes in R&D activities and discloses R&D expenses of ¥18 million for the interim period.
  3. FY2025-H1RestatedAnnual report

    「R&D expenses for the current interim consolidated accounting period totaled ¥18 million. There were no material changes in the status of the Group’s R&D activities during the current interim consolidated accounting period.」

    Reconfirms that there were no material changes in R&D activities and discloses R&D expenses of ¥18 million for the current interim period.
  4. FY2024-Q3RestatedAnnual report

    「R&D expenses for the cumulative third quarter of the current fiscal year totaled ¥27 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter of the current fiscal year.」

    Reconfirms that there were no material changes in R&D activities and discloses R&D expenses of ¥27 million for the cumulative third quarter of the current fiscal year.
  5. FY2024-Q2RestatedAnnual report

    「Total R&D expenses for the six-month period of the second quarter of the current consolidated fiscal year were ¥19 million. There were no material changes in the status of the group's R&D activities during the six-month period of the second quarter of the current consolidated fiscal year.」

    Reconfirms that there were no material changes in R&D activities and discloses R&D expenses of ¥19 million for the cumulative second quarter of the current fiscal year.
  6. FY2023RestatedAnnual report

    「The Group is engaged in development aimed at reducing costs and improving safety technology in order to maintain and enhance its technological capabilities as a specialist gas manufacturer. R&D expenses for the current fiscal year totaled ¥40 million and related to the gas-related business.」

    Continues gas-related R&D aimed at reducing costs, improving safety technology, ensuring stable supply and developing new applications.
  7. FY2023-Q3RestatedAnnual report

    「Total R&D expenses for the nine-month period of the third quarter of the current consolidated fiscal year were ¥31 million. There were no material changes in the status of the group's R&D activities during the nine-month period of the third quarter of the current consolidated fiscal year.」

    Reconfirms that there were no material changes in R&D activities involving gas-related technologies and other areas, and discloses R&D expenses of ¥31 million for the cumulative third quarter of the current fiscal year.
  8. FY2023-Q2RestatedAnnual report

    「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥21 million. There were no significant changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」

    Reconfirms that there were no material changes in R&D activities involving gas-related technologies and other areas, and discloses R&D expenses of ¥21 million for the cumulative second quarter of the current fiscal year.
  9. FY2023-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative consolidated first quarter were ¥11 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated first quarter.」

    Continues R&D into gas-related technologies and other areas, and discloses R&D expenses of ¥11 million for the current quarter.
  10. FY2022RestatedAnnual report

    「The Group is engaged in development aimed at reducing costs and improving safety technology in order to maintain and enhance its technological capabilities as a specialist gas manufacturer. R&D expenses for the current fiscal year totaled ¥43 million and related to the gas-related business.」

    Continues gas-related R&D aimed at reducing costs, improving safety technology, ensuring stable supply and developing new applications, and records R&D expenses of ¥43 million.
  11. FY2022-Q3RestatedAnnual report

    「R&D expenses for the cumulative third quarter of the current fiscal year totaled ¥32 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter of the current fiscal year.」

    Reconfirms that there were no material changes in R&D activities and reports R&D expenses of ¥32 million for the cumulative third quarter of the current fiscal year.
  12. FY2022-Q2RestatedAnnual report

    「Total research and development expenses for the six months ended the second quarter of the current consolidated fiscal year were ¥22 million. There were no material changes in the status of the Group's research and development activities during the period.」

    Reconfirms that there were no material changes in R&D activities and reports R&D expenses of ¥22 million for the cumulative second quarter of the current fiscal year.
  13. FY2022-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative consolidated first quarter were ¥10 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated first quarter.」

    Reconfirms that there were no material changes in R&D activities and reports R&D expenses of ¥10 million for the current quarter.
  14. FY2021-Q3RestatedAnnual report

    「R&D expenses for the cumulative third quarter of the current fiscal year totaled ¥27 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter of the current fiscal year.」

    States that there were no material changes in R&D activities and reports R&D expenses of ¥27 million for the cumulative third quarter of the current fiscal year.
  15. FY2020-Q3RestatedAnnual report

    「R&D expenses for the cumulative third quarter of the current fiscal year totaled ¥27 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter of the current fiscal year.」

    States that there were no material changes in R&D activities and records R&D expenses of ¥27 million.
  16. FY2019-Q3RestatedAnnual report

    「R&D expenses for the cumulative third quarter of the current fiscal year totaled ¥27 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter of the current fiscal year.」

    States that there were no material changes in R&D activities and reports R&D expenses of ¥27 million for the cumulative third quarter of the current fiscal year.
  17. FY2019-Q2RestatedAnnual report

    「R&D expenses for the cumulative second quarter of the current fiscal year totaled ¥18 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter of the current fiscal year.」

    States that there were no material changes in R&D activities and reports R&D expenses of ¥18 million for the cumulative second quarter of the current fiscal year.
  18. FY2019-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative consolidated first quarter were ¥9 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated first quarter.」

    The Company states that there were no material changes in its research and development activities and reports research and development expenses of ¥9 million for the quarter.
  19. FY2018-Q3RestatedAnnual report

    「Total research and development expenses for the nine-month period of the third quarter of the current consolidated fiscal year were ¥30 million.」

    Research and development activities continued, with ¥30 million recorded as research and development expenses for the nine-month period of the third quarter.
  20. FY2018-Q2RestatedAnnual report

    「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥22 million.」

    Research and development activities continued, with research and development expenses of ¥22 million reported for the six-month period of the second quarter.
  21. FY2018-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥12 million.」

    The Company reports quarterly research and development expenses, indicating that research and development activities continued.
  22. FY2017RestatedAnnual report

    「As a dedicated gas manufacturer, the Group is engaged in development that contributes to cost reductions and improvements in safety technologies to maintain and enhance its technical capabilities. Research and development expenses for the current consolidated fiscal year were ¥54 million, all of which related to the gas-related business.」

    The Company continued developing technologies related to cost reductions, improvements in safety technologies and gas, and recorded research and development expenses of ¥54 million.
  23. FY2017-Q3RestatedAnnual report

    「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal year were ¥42 million.」

    The Company indicates that research and development activities continued, with research and development expenses of ¥42 million for the nine-month period of the third quarter of the current consolidated fiscal year.
  24. FY2017-Q2RestatedAnnual report

    「Total research and development expenses for the six-month period of the second quarter of the current consolidated fiscal year were ¥29 million.」

    Research and development activities continued, with research and development expenses of ¥29 million reported for the six-month period of the second quarter.
  25. FY2017-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥17 million.」

    Research and development activities continued, with research and development expenses of ¥17 million reported for the quarter.
  26. FY2016First statedAnnual report

    「As a dedicated gas manufacturer, the Group is engaged in developing gas production and supply technologies and technologies for gas utilization.」

    The Company lists development initiatives including high purification, container cleaning, remote monitoring, residual-liquid monitoring and agricultural carbon dioxide application. Research and development expenses were ¥72 million.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Toho Acetylene's next results are scheduled for 2026-11-12. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.